Evidence map›Paper›PMID 34837482›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Nanopore Whole Transcriptome Analysis and Pathogen Surveillance by a Novel Solid-Phase Catalysis Approach.

Yi Fang, Amogh Changavi, Manyun Yang, Luo Sun, Aihua Zhang, Daniel Sun, Zhiyi Sun, Boce Zhang, Ming-Qun Xu

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yi FangNew England Biolabs, Inc., Ipswich, MA, 01938, USA.ORCID 0000-0003-2583-328X
Amogh ChangaviNew England Biolabs, Inc., Ipswich, MA, 01938, USA.
Manyun YangDepartment of Microbiology and Immunology, Cornell University, Ithaca, NY, 14853, USA.
Luo SunNew England Biolabs, Inc., Ipswich, MA, 01938, USA.
Aihua ZhangNew England Biolabs, Inc., Ipswich, MA, 01938, USA.
Daniel SunNew England Biolabs, Inc., Ipswich, MA, 01938, USA.
Zhiyi SunNew England Biolabs, Inc., Ipswich, MA, 01938, USA.
Boce ZhangDepartment of Food Science and Human Nutrition, University of Florida, Gainesville, FL, 32603, USA.
Ming-Qun XuNew England Biolabs, Inc., Ipswich, MA, 01938, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The requirement of a large input amount (500 ng) for Nanopore direct RNA-seq presents a major challenge for low input transcriptomic analysis and early pathogen surveillance. The high RNA input requirement is attributed to significant sample loss associated with library preparation using solid-phase reversible immobilization (SPRI) beads. A novel solid-phase catalysis strategy for RNA library preparation to circumvent the need for SPRI bead purification to remove enzymes is reported here. This new approach leverages concurrent processing of non-polyadenylated transcripts with immobilized poly(A) polymerase and T4 DNA ligase, followed by directly loading the prepared library onto a flow cell. Whole transcriptome sequencing, using a human pathogen Listeria monocytogenes as a model, demonstrates this new method displays little sample loss, takes much less time, and generates higher sequencing throughput correlated with reduced nanopore fouling compared to the current library preparation for 500 ng input. Consequently, this approach enables Nanopore low-input direct RNA-seq, improving pathogen detection and transcript identification in a microbial community standard with spike-in transcript controls. Besides, as evident in the bioinformatic analysis, the new method provides accurate RNA consensus with high fidelity and identifies higher numbers of expressed genes for both high and low input RNA amounts.

Indexed as

NanoporesComputational BiologyGene Expression ProfilingHigh-Throughput Nucleotide SequencingHumansSequence Analysis, RNAdirect RNA-seqfoodborne pathogenimmobilized enzymesnext-generation sequencingOxford Nanopore Technologiestranscriptome

Identifiers

PMID34837482
PMCPMC8787394

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.